Brainlab
Address: Olof-Palme-Straße 9, Munich, 81829About Us
At Brainlab, we digitize medical workflows, from diagnosis to therapy, to offer clinicians and patients better treatment possibilities. Our innovative digital ecosystem forms the basis for modern healthcare technology in 6,700 hospitals in 127 countries. At the forefront of health technology for over 35 years, Munich-based Brainlab employs around 2,400 people with expertise across the entire healthcare value chain in 25 locations worldwide. At Brainlab, we digitize medical workflows from diagnosis to therapy, and our innovative ecosystem forms the basis for modern healthcare technology. We help healthcare providers build three-dimensional patient-specific models with data that is structured, mapped and aggregated with industry-leading artificial intelligence. This builds the basis of our navigation system for the human body, clinicians can safely remove brain tumors, place screws in the spine precisely, and irradiate breast tumors with millimetric precision. Our robotics and mixed reality technologies and expertise allow users to connect and innovate between the digital and physical worlds. In addition, Brainlab technologies power the collection of structured long-term data and medical registries. Through the neuroscience of play, Brainlab advances clinical training and education, promoting the adaptation to technological advances and creating digital models of complete interventions. Our digital ecosystem is an open interface and forms a framework for third parties to accelerate innovation in other clinical areas as well.
Sectors
- Collaborations & Partnerships- R&D
- Medtech
- Software Services
Categories
- Software
- Software-3D
- Software-Data Evaluation
- Surgical Products
- Platform Technology-Drug Development
- Platform Technology-Drug Discovery
- Neuroscience
- Neurology Products
- Neuro-degenerative Diseases
- Drug Development Services
- Drug Discovery Services
News
Brainlab, Precision NeuroMed Partner on AI-Enabled Drug Delivery to Brain
Brainlab and Precision NeuroMed have a new strategic partnership for an artificial intelligence (AI)-enabled treatment planning platform. Once developed and commercialized, this platform will facilitate convection enhanced delivery (CED) to the brain.
There are long-standing limitations in this area of medicine, the companies say, due to the blood-brain barrier. For the most part, systemically administered drugs usually cannot reach therapeutic concentrations in the brain.
Source: The Partnership Tree | https://www.pharmaservicesdirectory.com